Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
10.85
-0.28 (-2.52%)
At close: Dec 19, 2025, 4:00 PM EST
10.91
+0.06 (0.55%)
After-hours: Dec 19, 2025, 7:54 PM EST
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.44 billion as of December 19, 2025. Its market cap has decreased by -69.09% in one year.
Market Cap
1.44B
Enterprise Value
1.49B
1-Year Change
-69.09%
Ranking
Category
Stock Price
$10.85
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.44B, an increase of 450.38%. That is a compound annual growth rate of 69.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.44B | -61.88% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |